Skip to content

Author

Leila Mirzakhani

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Comparison of Mirtazapine versus Olanzapine for the Prevention of Chemotherapy-induced Nausea and Vomiting in Highly Emetogenic Chemotherapy: A Double-blind Randomized Crossover Trial

A BSTRACT Chemotherapy-induced nausea and vomiting (CINV) is a distressing complication of chemotherapy. It can compromise treatment adherence and impair patients’ quality of life. Despite guideline-recommended drug prophylaxis, many patients still suffer from CINV. This double-blind, randomized crossover cli...

Fatemeh Farzameh, Ehsan Zaboli, M. Eslamijouybari et al. · 0 citations
Open access Jul 2026

Altered expression of ET-1 and HMGB1 together with higher MMP-9 activity in serum-derived exosomes of chronic lymphocytic leukemia.

Findings showed that serum-derived exosomes from CLL patients have higher expression of ET-1 and HMGB1 and higher MMP-9 enzymatic activity, which suggest that exosomal ET-1, HMGB1, and MMP-9 may serve as potential non-invasive biomarkers for disease monitoring and warrant further investigation regarding their biologica...

Maryam Ghotbbahaei, Amirhossein Amoei, Maryam Lotfi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.